CN105324112B - 用于治疗腹泻的产品和方法 - Google Patents

用于治疗腹泻的产品和方法 Download PDF

Info

Publication number
CN105324112B
CN105324112B CN201480022471.0A CN201480022471A CN105324112B CN 105324112 B CN105324112 B CN 105324112B CN 201480022471 A CN201480022471 A CN 201480022471A CN 105324112 B CN105324112 B CN 105324112B
Authority
CN
China
Prior art keywords
diarrhea
patient
receptor antagonist
patients
cetirizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480022471.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN105324112A (zh
Inventor
R.B.霍根二世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maregade Rx LLC
Original Assignee
Maregade Rx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maregade Rx LLC filed Critical Maregade Rx LLC
Priority to CN201810755897.7A priority Critical patent/CN108939076A/zh
Publication of CN105324112A publication Critical patent/CN105324112A/zh
Application granted granted Critical
Publication of CN105324112B publication Critical patent/CN105324112B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201480022471.0A 2013-03-14 2014-03-14 用于治疗腹泻的产品和方法 Active CN105324112B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810755897.7A CN108939076A (zh) 2013-03-14 2014-03-14 用于治疗腹泻的产品和方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361782608P 2013-03-14 2013-03-14
US61/782,608 2013-03-14
PCT/US2014/027323 WO2014152420A2 (en) 2013-03-14 2014-03-14 Product and method for treating diarrhea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201810755897.7A Division CN108939076A (zh) 2013-03-14 2014-03-14 用于治疗腹泻的产品和方法

Publications (2)

Publication Number Publication Date
CN105324112A CN105324112A (zh) 2016-02-10
CN105324112B true CN105324112B (zh) 2018-08-17

Family

ID=50680150

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201810755897.7A Pending CN108939076A (zh) 2013-03-14 2014-03-14 用于治疗腹泻的产品和方法
CN201480022471.0A Active CN105324112B (zh) 2013-03-14 2014-03-14 用于治疗腹泻的产品和方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201810755897.7A Pending CN108939076A (zh) 2013-03-14 2014-03-14 用于治疗腹泻的产品和方法

Country Status (20)

Country Link
US (4) US9717726B2 (enExample)
EP (3) EP3581205A3 (enExample)
JP (4) JP6313417B2 (enExample)
KR (4) KR20180088514A (enExample)
CN (2) CN108939076A (enExample)
AU (3) AU2014239878B2 (enExample)
BR (2) BR122017004716A2 (enExample)
CA (1) CA2906005C (enExample)
DK (1) DK2968205T3 (enExample)
ES (2) ES2743604T3 (enExample)
HK (1) HK1247557B (enExample)
HU (1) HUE035201T2 (enExample)
IL (3) IL273377B2 (enExample)
MX (2) MX366329B (enExample)
MY (1) MY175326A (enExample)
PL (1) PL2968205T3 (enExample)
PT (1) PT2968205T (enExample)
RU (1) RU2015143475A (enExample)
WO (1) WO2014152420A2 (enExample)
ZA (1) ZA201708539B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717726B2 (en) * 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
WO2015073573A1 (en) * 2013-11-14 2015-05-21 Jacobs Michael M Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea
IT201900012645A1 (it) * 2019-07-23 2021-01-23 Eros Zanotti Una composizione farmaceutica per l'uso nel trattamento delle chinetosi
CN112616320B (zh) * 2019-08-05 2024-04-05 株式会社日立高新技术 等离子处理装置
US20220408780A1 (en) * 2020-02-11 2022-12-29 The E. Wolfson Medical Center A method effective for treating ulcerative colitis
CA3233054A1 (en) * 2021-09-22 2023-03-30 Hista Rx Llc Compositions and methods for treating and preventing interstitial cystitis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5096894A (en) * 1990-04-03 1992-03-17 Bristol-Myers Squibb Company Rice dextrin oral rehydration solution
AU7255094A (en) 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
WO2002043649A2 (en) 2000-11-30 2002-06-06 The Bio Balance Corp. Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
US6264984B1 (en) * 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
WO2003044023A1 (en) * 2001-11-23 2003-05-30 Janssen Pharmaceutica N.V. The use of anti-histaminics for acute reduction of elevated intracranial pressure
SE528789C2 (sv) 2004-09-10 2007-02-13 Sandvik Intellectual Property PVD-belagt skär av hårdmetall samt sätt att tillverka detta
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US20090312358A1 (en) 2006-03-22 2009-12-17 Trustees Of Boston University Method for management of diarrhea
US8207188B2 (en) 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20090042972A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
EP2559434A3 (en) 2007-02-12 2013-05-29 Mike Nicolaou Treatment of COPD using a histidine decarboxylase inhibitor sole or combined with an anti-H1 drug or with a leucotriene receptor antagonist
EP2148659A2 (en) * 2007-04-13 2010-02-03 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
EP3415627A1 (en) 2012-11-13 2018-12-19 Codiak BioSciences, Inc. Delivery of therapeutic agent
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Mastocytic Enterocolitis: Increased Mucosal Mast Cells in Chronic Intractable Diarrhea;Shriram Jakate等人;《Arch Pathol Lab Med》;20060331;第130卷;第362-367页 *

Also Published As

Publication number Publication date
US10034875B2 (en) 2018-07-31
MX366329B (es) 2019-07-05
HK1213205A1 (en) 2016-06-30
EP2968205B1 (en) 2017-10-11
BR112015022513A2 (pt) 2017-07-18
US11058681B2 (en) 2021-07-13
AU2014239878A1 (en) 2015-10-15
JP6313417B2 (ja) 2018-04-18
AU2014239878B2 (en) 2017-08-24
PT2968205T (pt) 2018-01-05
AU2017251701B2 (en) 2019-03-14
MX350814B (es) 2017-09-21
HUE035201T2 (hu) 2018-05-02
IL273377A (en) 2020-05-31
DK2968205T3 (da) 2017-11-27
JP6473254B2 (ja) 2019-02-20
US9717726B2 (en) 2017-08-01
KR102449977B1 (ko) 2022-09-30
US20170049770A1 (en) 2017-02-23
IL256300B (en) 2020-04-30
JP2016513692A (ja) 2016-05-16
EP3269364B1 (en) 2019-05-29
WO2014152420A2 (en) 2014-09-25
CN105324112A (zh) 2016-02-10
JP2018135340A (ja) 2018-08-30
KR20150139535A (ko) 2015-12-11
IL273377B1 (en) 2023-06-01
JP2019089796A (ja) 2019-06-13
JP6790140B2 (ja) 2020-11-25
MX2015011885A (es) 2016-05-16
US20140275116A1 (en) 2014-09-18
BR122017004716A2 (pt) 2019-07-30
AU2019201412A1 (en) 2019-03-21
PL2968205T3 (pl) 2018-03-30
US20220047583A1 (en) 2022-02-17
HK1247557B (en) 2020-07-03
ZA201708539B (en) 2019-05-29
ES2743604T3 (es) 2020-02-20
IL241372A0 (en) 2015-11-30
KR20200100211A (ko) 2020-08-25
CA2906005A1 (en) 2014-09-25
RU2015143475A (ru) 2017-04-20
EP3581205A3 (en) 2020-03-25
IL241372B (en) 2018-06-28
KR101884506B1 (ko) 2018-08-01
CA2906005C (en) 2021-12-28
KR20210021606A (ko) 2021-02-26
CN108939076A (zh) 2018-12-07
US20190038619A1 (en) 2019-02-07
ES2655505T3 (es) 2018-02-20
IL273377B2 (en) 2023-10-01
EP2968205A2 (en) 2016-01-20
IL256300A (en) 2018-02-28
EP3269364A1 (en) 2018-01-17
MY175326A (en) 2020-06-19
AU2017251701A1 (en) 2017-11-09
KR20180088514A (ko) 2018-08-03
WO2014152420A3 (en) 2014-11-20
JP2021046400A (ja) 2021-03-25
EP3581205A2 (en) 2019-12-18

Similar Documents

Publication Publication Date Title
CN105324112B (zh) 用于治疗腹泻的产品和方法
HK1247557A1 (en) Product and method for treating diarrhea
US20250325540A1 (en) Low dose product and method for treating diarrhea
HK1213205B (en) Product and method for treating diarrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant